灵灵九生物|化工原料平台|009

主页 > 生物化工 > 生化试剂 >

西地尼布马来酸盐

中文名称:
西地尼布马来酸盐
中文同义词:
西地尼布马来酸盐;西地尼布马来酸盐1;VEGFR2抑制剂(CEDIRANIB MALEATE)
英文名称:
Cediranib Maleate
英文同义词:
Cediranib Maleate;AZD 2171 Maleate;West to Ni BuMa Maleate;Cediranib Maleate(AZD-2171);4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline maleate;Cediranib maleate (AZD-2171 maleate;AZD-2171 MALEATE;AZD 2171 MALEATE
CAS号:
857036-77-2
分子式:
C25H27FN4O3·C4H4O4
分子量:
0
EINECS号:
相关类别:
抗肿瘤类药物及免疫抑制剂;医药类;细胞生物学试剂;API;API
Mol文件:
Mol File
熔点 
198.3-200.08 °C (polymorph)
生物活性
Cediranib maleate (AZD-2171 maleate) 是高选择性,有口服活性的 VEGFR2 抑制剂,对Flt1,KDR,Flt4,PDGFRα,PDGFRβ,c-Kit的 IC50 值分别为小于1, 小于3,5,5,36,2nM。
靶点
Target Value VEGFR2/KDR (HUVECs) 0.5 nM c-Kit (HUVECs) 2 nM c-Kit (HUVECs) 2 nM VEGFR3/FLT4 (HUVECs) <=3 nM VEGFR1/FLT1 (HUVECs) 5 nM
Target
Value
VEGFR2/KDR (HUVECs)
0.5 nM
c-Kit (HUVECs)
2 nM
c-Kit (HUVECs)
2 nM
VEGFR3/FLT4 (HUVECs)
<=3 nM
VEGFR1/FLT1 (HUVECs)
5 nM
体外研究
In human umbilical vein endothelial cells, Cediranib inhibits VEGF-stimulated proliferation and KDR phosphorylation with IC 50 values of 0.4 and 0.5 nM, respectively. In a fibroblast/endothelial cell coculture model of vessel sprouting, Cediranib also reduces vessel area, length, and branching at subnanomolar concentrations.
体内研究
Once-daily oral administration of Cediranib ablates experimental (VEGF-induced) angiogenesis and inhibits endochondral ossification in bone or corpora luteal development in ovary; physiologic processes that are highly dependent upon neovascularization. The growth of established human tumor xenografts (colon, lung, prostate, breast, and ovary) in athymic mice is inhibited dose-dependently by Cediranib, with chronic administration of 1.5 mg per kg per day producing statistically significant inhibition in all models. A histologic analysis of Calu-6 lung tumors treated with Cediranib reveals a reduction in microvessel density within 52 hours that becomes progressively greater with the duration of treatment. These changes are indicative of vascular regression within tumors.
价       格:请咨询卖家
CAS    号: 857036-77-2
规       格:10g/20g/100g/1kg
咨询电话:15623309010
正品保障
正规发票
闪电发货
满199包邮
详细介绍
英文名:
Cediranib Maleate
外观:
纯度:
请咨询卖家
分子式:
C25H27FN4O3·C4H4O4
分子量:
0
中文名称:
西地尼布马来酸盐
中文同义词:
西地尼布马来酸盐;西地尼布马来酸盐1;VEGFR2抑制剂(CEDIRANIB MALEATE)
英文名称:
Cediranib Maleate
英文同义词:
Cediranib Maleate;AZD 2171 Maleate;West to Ni BuMa Maleate;Cediranib Maleate(AZD-2171);4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline maleate;Cediranib maleate (AZD-2171 maleate;AZD-2171 MALEATE;AZD 2171 MALEATE
CAS号:
857036-77-2
分子式:
C25H27FN4O3·C4H4O4
分子量:
0
EINECS号:
相关类别:
抗肿瘤类药物及免疫抑制剂;医药类;细胞生物学试剂;API;API
Mol文件:
Mol File
熔点 
198.3-200.08 °C (polymorph)
生物活性
Cediranib maleate (AZD-2171 maleate) 是高选择性,有口服活性的 VEGFR2 抑制剂,对Flt1,KDR,Flt4,PDGFRα,PDGFRβ,c-Kit的 IC50 值分别为小于1, 小于3,5,5,36,2nM。
靶点
Target Value VEGFR2/KDR (HUVECs) 0.5 nM c-Kit (HUVECs) 2 nM c-Kit (HUVECs) 2 nM VEGFR3/FLT4 (HUVECs) <=3 nM VEGFR1/FLT1 (HUVECs) 5 nM
Target
Value
VEGFR2/KDR (HUVECs)
0.5 nM
c-Kit (HUVECs)
2 nM
c-Kit (HUVECs)
2 nM
VEGFR3/FLT4 (HUVECs)
<=3 nM
VEGFR1/FLT1 (HUVECs)
5 nM
体外研究
In human umbilical vein endothelial cells, Cediranib inhibits VEGF-stimulated proliferation and KDR phosphorylation with IC 50 values of 0.4 and 0.5 nM, respectively. In a fibroblast/endothelial cell coculture model of vessel sprouting, Cediranib also reduces vessel area, length, and branching at subnanomolar concentrations.
体内研究
Once-daily oral administration of Cediranib ablates experimental (VEGF-induced) angiogenesis and inhibits endochondral ossification in bone or corpora luteal development in ovary; physiologic processes that are highly dependent upon neovascularization. The growth of established human tumor xenografts (colon, lung, prostate, breast, and ovary) in athymic mice is inhibited dose-dependently by Cediranib, with chronic administration of 1.5 mg per kg per day producing statistically significant inhibition in all models. A histologic analysis of Calu-6 lung tumors treated with Cediranib reveals a reduction in microvessel density within 52 hours that becomes progressively greater with the duration of treatment. These changes are indicative of vascular regression within tumors.
优质服务
客服电话 1562309010
正品保障 正品保障  提供发票
急速物流 现货闪电  当时发货
售后无忧 不满意退货